Table 2

HRs and 95% CIs for the association between fatty pancreas and T2DM incidence, based on pancreas attenuation

All of the participants (n = 813)
CrudeAge and sex adjustedMultivariate adjusted
HR (95% CI)P valueHR (95% CI)P valueHR (95% CI)P value
Pancreas attenuation (continuous)0.97 (0.96–0.99)0.00460.98 (0.96–1.00)0.0471.00 (0.98–1.02)0.95
Age (continuous)1.02 (0.99–1.04)0.291.04 (1.01–1.07)0.021
Men2.84 (1.13–7.13)0.0271.76 (0.69–4.50)0.24
BMI (continuous)1.18 (1.08–1.29)<0.001
Liver attenuation (continuous)0.95 (0.93–0.97)<0.001
Alcohol intake ≥20 g/day1.43 (0.82–2.49)0.20
  • Cox proportional hazards models were used to estimate the HRs, 95% CIs, and P values. Fatty pancreas was assessed by attenuation in the pancreas on unenhanced CT at baseline; the more severe the fatty pancreas, the lower the attenuation in the pancreas.